Active	Status	Sponsor type	Region	Phase	Filter
5 Active 4 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Brown, Cynthia J
ELEVAATE, NCT05856331: Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema	Active, not recruiting	2	99	Europe, US, RoW	SAR447537, Zemaira, Respreeza	Sanofi	Alpha 1-Antitrypsin Deficiency, Emphysema	08/25	10/25
NCT04798014: HERO-2: Home-Reported Outcomes With CFTR Modulator Therapy	Completed	N/A	860	US		Indiana University, Folia Health, Cystic Fibrosis Foundation	Cystic Fibrosis	08/23	08/23
HOPeCF, NCT06296394: Health Outcomes of Parents With Cystic Fibrosis-Aim 2	Recruiting	N/A	146	US	Parenthood	University of Pittsburgh, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI)	Cystic Fibrosis, Parenthood Status	02/30	02/31
Pistenmaa, Carrie L
NCT05567562: Anti-Platelets in Chronic Obstructive Pulmonary Disease	Recruiting	2	30	US	dual anti-platelet therapy, aspirin 81mg EC tab, clopidogrel 75mg tab, Placebo	Brigham and Women's Hospital, National Heart, Lung, and Blood Institute (NHLBI)	COPD, Emphysema, Emphysema or COPD	02/25	06/25
ELEVAATE, NCT05856331: Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema	Active, not recruiting	2	99	Europe, US, RoW	SAR447537, Zemaira, Respreeza	Sanofi	Alpha 1-Antitrypsin Deficiency, Emphysema	08/25	10/25